These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4983480)

  • 1. Effects of diphenylhydantoin (Dilantin) withdrawal on non-epileptics: preliminary report.
    Rosenblum JA; Shafer N
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):31-3. PubMed ID: 4983480
    [No Abstract]   [Full Text] [Related]  

  • 2. Diphenylhydantoin sodium (Dilantin) withdrawal in non-epileptics.
    Rosenblum JA
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):369-73. PubMed ID: 4996223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phenytoin-induced hypersensitivity reaction with liver failure].
    Colombo-Arnet E
    Praxis (Bern 1994); 2000 Apr; 89(16):675-7. PubMed ID: 10823022
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum concentrations of diphenylhydantoin (phenytoin) and phenobarbital and their relation to therapeutic and toxic effects.
    Buchthal F; Svensmark O
    Psychiatr Neurol Neurochir; 1971; 74(2):117-36. PubMed ID: 5004709
    [No Abstract]   [Full Text] [Related]  

  • 5. Central effects of diphenylhydantoin (dilantin) in epileptic oligophrenics during phenobarbital-primidone withdrawal, sodium bicarbonate, and ammonium chloride administration.
    Matti N; Viukari A; Tammisto P
    Behav Neuropsychiatry; 1969 Nov; 1(8):13-6. PubMed ID: 5374542
    [No Abstract]   [Full Text] [Related]  

  • 6. The multiple system effects of diphenylhydantoin (Dilantin).
    Lindall AW
    Minn Med; 1969 Feb; 52(2):337-44. PubMed ID: 5764821
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of alcohol withdrawal seizures: the roles of diphenylhydantoin and chlordiazepoxide.
    Rothstein E
    Am J Psychiatry; 1973 Dec; 130(12):1381-2. PubMed ID: 4796341
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive effects of phenytoin during monotherapy and after withdrawal.
    Gallassi R; Morreale A; Lorusso S; Ferrari M; Procaccianti G; Lugaresi E; Baruzzi A
    Acta Neurol Scand; 1987 Apr; 75(4):258-61. PubMed ID: 3591275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central effect of diphenylhydantoin (Dilantin) in epileptic oligophrenics during phenobarbital-primidone withdrawal, sodium bicarbonate, and ammonium chloride administration.
    Viukari NM; Tammisto P
    Behav Neuropsychiatry; 1969 Nov; 1(8):13-6. PubMed ID: 5407671
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of optimal diphenylhydantoin dosage by monitoring serum concentrations].
    Weintraub M; Halkin H; Shaked Y; Almog S
    Harefuah; 1980 Oct; 99(8):213-5. PubMed ID: 7215973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 5,5-diphenylhydantoin and pneumoencephalography on urinary excretion of 5-hydroxyindoloacetic acid, a serotonin metabolite, and serum ceruloplasmin activity in epileptics].
    Pakszys W
    Neurol Neurochir Pol; 1971; 5(3):311-6. PubMed ID: 5116782
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug treatment of epilepsy.
    Aminoff MJ
    Compr Ther; 1981 Apr; 7(4):6-12. PubMed ID: 6786823
    [No Abstract]   [Full Text] [Related]  

  • 13. Diphenylhydantoin control of alcohol withdrawal seizures. Results of a controlled study.
    Sampliner R; Iber FL
    JAMA; 1974 Dec; 230(10):1430-2. PubMed ID: 4610196
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum level of phenobarbital or/and diphenylhydantoin in epileptics with some preexisting serum lipid alterations. Correlations with the treatment efficiency in epilepsy.
    Rogozea R; Florea-Ciocoiu V; Balaita C; Luca N
    Acta Neurol Belg; 1981; 81(1):24-32. PubMed ID: 7223355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The eosinophilic fasciitis syndrome after phenytoin (dilantin) therapy.
    Buchanan RR; Gordon DA; Muckle TJ; McKenna F; Kraag G
    J Rheumatol; 1980; 7(5):733-6. PubMed ID: 7441663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of blood levels with oral and intramuscular diphenylhydantoin.
    Cantu RC; Schwab RS; Timberlake WH
    Neurology; 1968 Aug; 18(8):782-4. PubMed ID: 5692338
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug withdrawal after successful epilepsy surgery: how safe is it?
    Kerling F; Pauli E; Lorber B; Blümcke I; Buchfelder M; Stefan H
    Epilepsy Behav; 2009 Aug; 15(4):476-80. PubMed ID: 19546031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of Dilantin on the EEG of epileptic patients: a quantitative study.
    Riehl JL; McIntyre HB
    Electroencephalogr Clin Neurophysiol; 1970 Jan; 28(1):94. PubMed ID: 4188512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Daily fluctuations of plasma diphenylhydantoin in patients treated with diphenylhydantoin and sodium valproate].
    Pisani F; Di Perri R
    Acta Neurol (Napoli); 1981 Feb; 3(1):61-3. PubMed ID: 6787844
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Treatment of ethanol intoxication.
    N Engl J Med; 1976 Jul; 295(2):109-10. PubMed ID: 1272307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.